Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28194187 | 1.00 | TRPA1 (0.59) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL7139129 | 1.00 | TRPA1 (0.59) | TRPA1PTPN1TTRALOX5PTGS1 | |
| Resveratrol SCHEMBL27943459 | 0.87 | PTPN1 (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL27677458 | 0.82 | PTPN1 (0.76) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL21686 | 0.82 | TRPA1 (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL9742095 | 0.82 | TRPA1 (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL30728934 | 0.82 | TRPA1 (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL1982134 | 0.81 | TTR (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL3681557 | 0.81 | TTR (0.61) | TRPA1PTPN1TTRALOX5PTGS1 | |
| SCHEMBL13339166 | 0.81 | TRPA1 (0.65) | TRPA1PTPN1TTRALOX5PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024238399-A1 | METHODS OF MANUFACTURING ADENO-ASSOCIATED VIRAL VECTORS | SIREN BIOTECHNOLOGY, INC. (US) | 2024-11-21 | — | — | WO | claimed |
| EP-4427758-A1 | NEW SYNERGISTIC ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIBACTERIAL ASSOCIATION | NOOS S.r.l. (IT) | 2024-09-11 | — | — | EP | claimed |
| CN-116751237-B | Mitochondrial targeting stilbene glucoside derivative and preparation method and application thereof | 遵义医科大学第五附属(珠海)医院 | 2023-12-05 | — | — | CN | claimed |
| CN-116751237-A | Mitochondrial targeting stilbene glucoside derivative and preparation method and application thereof | 遵义医科大学第五附属(珠海)医院 | 2023-09-15 | — | — | CN | claimed |
| US-20230141224-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | FIGENE, LLC | 2023-05-11 | — | — | US | claimed |
| EP-4142751-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | Figene, LLC (US) | 2023-03-08 | — | — | EP | claimed |
| CN-115616095-A | Method for measuring multi-component content of Xintong oral liquid | 鲁南厚普制药有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-113406241-B | Detection method of Xintong granules | 鲁南制药集团股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-114796470-A | Resveratrol compound and CAR-T cell targeting NKG2D ligand combined preparation of medicine for treating malignant tumor | 深圳宾德生物技术有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114628056-A | Light cable for railway vehicle and preparation method thereof | 刘金兰 | 2022-06-14 | — | — | CN | claimed |
| EP-1117394-A1 | COMBINATION OF CARNITINES AND RESVERATROL FOR PREVENTION OR TREATMENT OF CEREBRAL AND AGEING DISORDERS | Sigma-Tau Healthscience S.p.A. (IT) | 2001-07-25 | — | — | EP | claimed |
| CN-1303858-A | Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases | NO 2 MILITARY MEDICAL COLLEGE (CN) | 2001-07-18 | — | — | CN | claimed |
| WO-2001021165-A1 | RESVERATROL ANALOGS FOR PREVENTION OF DISEASE | RUTGERS, THE STATE UNIVERSITY (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2001012228-A2 | COMPOSITIONS FOR TREATING VIRAL INFECTIONS, AND METHODS THEREFOR | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2001-02-22 | — | — | WO | claimed |
| WO-2001008671-A2 | METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES | THE PROCTER & GAMBLE COMPANY (US) | 2001-02-08 | — | — | WO | claimed |
| CN-1270804-A | use of diphenyl styrene in cosmetic composition as deodoring active content | OREAL (FR) | 2000-10-25 | — | — | CN | claimed |
| WO-2000021526-A1 | COMBINATION OF CARNITINES AND RESVERATROL FOR PREVENTION OR TREATMENT OF CEREBRAL AND AGEING DISORDERS | SIGMA-TAU HEALTHSCIENCE S.P.A. (IT) | 2000-04-20 | — | — | WO | claimed |
| CN-1196245-A | Application of stilbene compound and its derivative in preparation of endothelium element antagonist agent | AIR FORCE GENERAL HOSPITAL PLA (CN) | 1998-10-21 | — | — | CN | claimed |
| US-5747536-A | ATHERIOSCLEROSIS AND CARDIOVASCULAR DISORDERS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1998-05-05 | — | — | US | claimed |
| EP-0773020-A2 | Pharmaceutical compositions containing L-carnitine or derivatives thereof in combination with resveratrol or derivatives thereof, for the prophylaxis and treatment of cardiovascular disorders, peripheral vascular diseases and peripheral diabetic neuropathy | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1997-05-14 | — | — | EP | claimed |